Chiou et al. FGFs and deal with the biomaterials based delivery systems and their current applications for the regeneration of tissues, including skin, blood vessel, muscle, adipose, tendon/ligament, cartilage, bone, tooth, and nerve tissues. == 1. Introduction == Tissue engineering, with significant research inputs over the last decades, has emerged as a potential tool to regenerate damaged and diseased tissues [1]. As one of the key components in tissue engineering approach, growth factors provide chemical cues to Tolazamide stem cells, regulating their biological responses and tissue differentiation. While the basic biological functions of growth factors and their endogenic functions in tissue development and repair process have relatively been well studied, the use of growth factors in tissue engineering regime has recently gained great interest. Growth factors are a potential agent to target specific tissue reactions because of their regulatory functions in cellular functions, including adhesion, proliferation, migration, and differentiation in the epithelium, bone, and soft Tolazamide connective tissues and nerves. Fibroblast growth factor (FGF) is usually a representative growth factor which has shown the potential effects on the repair and regeneration of tissues [26]. It was originally identified as a protein capable of promoting fibroblast proliferation and is now known to comprise 22 members. FGFs exert multiple functions through the binding into and activation of fibroblast growth factor receptors (FGFRs), and the main signaling through the stimulation of FGFRs is the RAS/MAP kinase pathway. With their potential biological functions, FGFs have been utilized for the regeneration of damaged tissues, including skin, blood vessel, muscle, adipose, tendon/ligament, cartilage, bone, tooth, and nerve. Then, the prospective source of FGF for the tissue regeneration is used with recombinant human FGF family. In fact, many previous studies administered the FGFs directly to the wound sites, like other growth factors. However, free-FGFs are readily degradablein vivo, leading to loss of biological activity and functions [79]. To gain acceptable performance, FGFs are adsorbed onto or encapsulated within materials to secure biological activity in a sustained and controllable manner. Although many types of materials have been developed to carry FGFs and elicit their therapeutic efficacyin vitroandin vivo, more sustained, controlled, and targeted delivering system still remain a challenge. Here, we review the cellular biology of FGFs and their functions in cell proliferation, migration, differentiation, and angiogenesis and address the current development of biomaterials-based delivery Tolazamide systems of FGFs and their applications for tissue regeneration, including skin, blood vessel, muscle, adipose, tendon/ligament, cartilage, bone, tooth, Rabbit Polyclonal to Histone H2A (phospho-Thr121) and nerve. == 2. Biology of FGF == FGF, which was first discovered in pituitary extracts in 1973, is usually widely expressed in cells and tissues. Acidic FGF (FGF1) and basic FGF (FGF2) were originally isolated from the brain and pituitary gland as growth factors for fibroblasts. Since then, at least 22 distinct FGFs have been identified or isolated. FGFs have been found in both vertebrates and invertebrates. Many FGF genes have been identified in vertebrates, including ten FGFs in zebrafish (FGF24, 6, 8, 10, 17a, 17b, 18, 24), six inXenopus(FGF24, 810), 13 in chickens (FGF14, 810, 12, 13, 16, 1820), 22 in mice (FGF118, 2023) and humans (FGF114, 1623), whereas only threeDrosophilaFGF genes and twoCaenorhabditis elegansFGF genes have been observed in invertebrates [10]. Human FGFs contain 22 members: FGF1, FGF2, FGF3 (INT2), FGF4, FGF5, FGF6, FGF7 (KGF), FGF8 (AIGF), FGF9, FGF10, FGF11, FGF12, FGF13, FGF14, FGF16, FGF17, FGF18, FGF19, FGF20, FGF21, FGF22, and FGF23 [11]. The FGF family comprises 23 members, although there are only 18 FGFR ligands. Four family members do not bind with FGFR as FGF homologous factors (FGF11, FGF12, FGF13, and FGF14) and are more correctly Tolazamide referred to as FGF homologous factors. In addition, there is no human FGF15 gene; the gene orthologous to mouse FGF15 is usually FGF19 [12]. By phylogenetic analysis, the human FGF gene family can be divided into seven subfamilies: FGF1, FGF4, FGF7, FGF8, FGF9, FGF11, and FGF19 (Physique 1). The FGF1, FGF4, FGF7, FGF8, FGF9, FGF11, and FGF19 subfamilies comprise FGF1 and 2, FGF4, 5, and 6, FGF3, 7, 10, and 22, FGF8, 17, and 18, FGF9, 16, and 20, FGF11, 12, 13, and 14, and FGF19, 21, and 23, respectively. In contrast to phylogenetic analysis, gene location analysis indicates that.